The disclosure is of and includes at least an apparatus, system and method for a print head for additive manufacturing. The apparatus, system and method may include at least two proximate hobs suitable to receive and extrude therebetween a print material filament for the additive manufacturing, each of the two hobs comprising two halves, wherein each of the hob halves comprises teeth that are offset with respect to the teeth of the opposing hob half; a motor capable of imparting a rotation to at least one of the two hobs, wherein the extrusion results from the rotation; and an interface to a hot end capable of outputting the print material filament after at least partial liquification to perform the additive manufacturing.

Systems and methods can be used to produce fibers with external corrugations, internal corrugations, or both. These fibers can be used, for example, in hollow fiber membrane modules.

Systems and methods can be used to produce fibers with external corrugations, internal corrugations, or both. These fibers can be used, for example, in hollow fiber membrane modules.

Example methods and articles of manufacture related to electrospun aramid nanofibers are provided. One example method may include forming a resultant solution by reacting a solution of aramids dissolved in a solvent with an electrophile. In this regard, the electrophile may perform a side chain substitution on the dissolved aramids. The example method may further include electrospinning the resultant solution to form an aramid nanofiber.

The present invention includes compositions and methods of making a modified release pharmaceutical formulation and a method of preparation for the embedding of modified release multi-particulates into a polymeric or wax-like matrix. The modified release multi-particulates comprise an effective amount of a therapeutic compound having a known or desired drug-release profile. Modified release multi-particulates may include a polymeric coat or may be incorporated into particle or core material. The polymer matrix comprises a thermoplastic polymer or lipophilic carrier or a mixture thereof that softens or melts at elevated temperature and allows the distribution of the modified release multi-particulates in the polymer matrix during thermal processing. Formulation compounds and processing conditions are selected in a manner to preserve the controlled release characteristics and/or drug-protective properties of the original modified release multi-particulates.

The invention relates to an extrude unit for a dryer (2) for biomass, in particular slurry, wherein the extruder unit (1) has a surface section (4) for the biomass to pass through and a plurality of apertures (3), wherein the extruder unit (1) comprises a base support (5) which is connected by means of a connecting section (6) to a driving element (7) and can be driven by means of the driving element (7) about an axis of rotation (8) and relative to the surface section (4), wherein the base support (5) comprises at least one support arm (9) having at least one scraper blade (10) which during a rotation of the base support (5) follows the shape of the face of the surface section (4) facing the scraper blade (10). According to the invention the base support (5) also comprises at least one breaker element (11) having at least one scraper blade (10) which during a rotation of the base support (5) also follows the shape of the face of the surface section (4) facing the scraper blade (10) and during the rotation of the base support (5) effects a crushing of constituents contained in the biomass which are retained by the surface section (4). The invention further relates to a dryer having at least one corresponding extruder unit.

The present disclosure relates to methods and systems for manufacturing rotational spun materials. The rotational spun materials are medical appliances or other prostheses made of, constructed from, covered or coated with rotational spun materials, such as polytetrafluoroethylene (PTFE).

Absorbable implants for breast surgery that conform to the breast parenchyma and surrounding chest wall have been developed. These implants support newly lifted breast parenchyma, and/or a breast implant. The implants have mechanical properties sufficient to support a reconstructed breast, and allow the in-growth of tissue into the implant as it degrades. The implants have a strength retention profile allowing the support of the breast to be transitioned from the implant to regenerated host tissue, without significant loss of support. Three-dimensional implants for use in minimally invasive mastopexy/breast reconstruction procedures are also described, that confer shape to a patient's breast. These implants are self-reinforced, can be temporarily deformed, implanted in a suitably dissected tissue plane, and resume their preformed three-dimensional shape. The implants are preferably made from poly-4-hydroxybutyrate (P4HB) and copolymers thereof. The implants have suture pullout strengths that can resist the mechanical loads exerted on the reconstructed breast.

Absorbable implants for breast surgery that conform to the breast parenchyma and surrounding chest wall have been developed. These implants support newly lifted breast parenchyma, and/or a breast implant. The implants have mechanical properties sufficient to support a reconstructed breast, and allow the in-growth of tissue into the implant as it degrades. The implants have a strength retention profile allowing the support of the breast to be transitioned from the implant to regenerated host tissue, without significant loss of support. Three-dimensional implants for use in minimally invasive mastopexy/breast reconstruction procedures are also described, that confer shape to a patient's breast. These implants are self-reinforced, can be temporarily deformed, implanted in a suitably dissected tissue plane, and resume their preformed three-dimensional shape. The implants are preferably made from poly-4-hydroxybutyrate (P4HB) and copolymers thereof. The implants have suture pullout strengths that can resist the mechanical loads exerted on the reconstructed breast.

A method utilizes waste product in manufacturing, such as manufacture of filaments or micro-pellets for use in manufacturing applications such as additive manufacturing, extrusion, injection molding, blow molding and other applications.